Surviving Sepsis Campaign Guidelines 2016: omission of selective decontamination of the digestive tract deprives patients of a level 2B therapy.Minerva Anestesiol. 2017 11; 83(11):1214-1215.MA
Links
Pub Type(s)
Letter
Language
eng
PubMed ID
28607344
Citation
Silvestri, Luciano, et al. "Surviving Sepsis Campaign Guidelines 2016: Omission of Selective Decontamination of the Digestive Tract Deprives Patients of a Level 2B Therapy." Minerva Anestesiologica, vol. 83, no. 11, 2017, pp. 1214-1215.
Silvestri L, van Saene HK, Rommes JH, et al. Surviving Sepsis Campaign Guidelines 2016: omission of selective decontamination of the digestive tract deprives patients of a level 2B therapy. Minerva Anestesiol. 2017;83(11):1214-1215.
Silvestri, L., van Saene, H. K., Rommes, J. H., Petros, A. J., de la Cal, M. A., & Bion, J. F. (2017). Surviving Sepsis Campaign Guidelines 2016: omission of selective decontamination of the digestive tract deprives patients of a level 2B therapy. Minerva Anestesiologica, 83(11), 1214-1215. https://doi.org/10.23736/S0375-9393.17.12105-X
Silvestri L, et al. Surviving Sepsis Campaign Guidelines 2016: Omission of Selective Decontamination of the Digestive Tract Deprives Patients of a Level 2B Therapy. Minerva Anestesiol. 2017;83(11):1214-1215. PubMed PMID: 28607344.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Surviving Sepsis Campaign Guidelines 2016: omission of selective decontamination of the digestive tract deprives patients of a level 2B therapy.
AU - Silvestri,Luciano,
AU - van Saene,Hendrick K,
AU - Rommes,Johannes H,
AU - Petros,Andy J,
AU - de la Cal,Miguel A,
AU - Bion,Julian F,
Y1 - 2017/06/12/
PY - 2017/6/14/pubmed
PY - 2019/9/5/medline
PY - 2017/6/14/entrez
SP - 1214
EP - 1215
JF - Minerva anestesiologica
JO - Minerva Anestesiol
VL - 83
IS - 11
SN - 1827-1596
UR - https://www.unboundmedicine.com/medline/citation/28607344/Surviving_Sepsis_Campaign_Guidelines_2016:_omission_of_selective_decontamination_of_the_digestive_tract_deprives_patients_of_a_level_2B_therapy_
L2 - https://www.minervamedica.it/index2.t?show=R02Y2017N11A1214
DB - PRIME
DP - Unbound Medicine
ER -